Yes. Carrier screening is a type of genetic testing that can identify whether an individual carries specific genetic variants associated with certain inherited conditions, even if no symptoms are present.
This information may be useful for family planning and risk awareness. However, carrier testing does not detect all genetic conditions and does not replace medical evaluation or counselling by a qualified healthcare professional.
Genetic testing may help identify whether a child has inherited specific genetic variants associated with certain conditions. This information can support risk assessment and future healthcare planning.
However, genetic findings do not predict disease certainty and must always be interpreted together with clinical evaluation, family history, and environmental factors by a qualified healthcare professional.
The interpretation of genetic testing results can be complex, so it’s important to discuss them with a healthcare provider or geneticist who can help you understand what they mean for your health and future medical care. They will provide guidance on any preventive measures or screening recommendations based on your results. Genetic test results are not diagnostic on their own and should not be used as the sole basis for medical decisions.
No, mRNA testing is not the same as DNA testing. DNA testing analyses an individual’s genetic material (DNA) to identify genetic variations, mutations, or predispositions to certain diseases. It provides information about an individual’s inherited genetic makeup. On the other hand, mRNA testing analyses messenger RNA (mRNA) molecules, which are used to produce proteins. mRNA testing is often used to measure gene expression levels, providing insights into which genes are active or inactive in a particular tissue or sample. While both types of testing are molecular techniques used in genetics and medical diagnostics, they serve different purposes. mRNA testing reflects gene expression at a specific point in time and does not diagnose disease or confirm disease progression.
The turnaround time would be 6 weeks.
Yes, mRNA testing can detect changes in gene expression in response to cancer treatments such as chemotherapy or targeted therapy. While this information may provide insights into treatment effects, it is not a standard method for monitoring treatment response in clinical practice. Instead, its primary role lies in tumour profiling and predicting response to immunotherapy at diagnosis or during disease progression, with treatment response typically assessed through imaging, blood tests, and clinical evaluation.
Yes, we do provide microbial test for the purpose of product quality control.
Mycoplasma:
A mycoplasma test is used to detect the presence of mycoplasma (a group of bacteria that lack cell walls and can cause significant interference in research and bioproduction) contamination in biological samples such as cell cultures, tissue cultures and clinical specimens.
Bacterial Endotoxin Test:
Bacterial Endotoxins Test (BET), also known as the Limulus Amebocyte Lysate (LAL) test, is a widely used assay to detect and quantify endotoxins from Gram negative bacteria in pharmaceuticals, medical devices, and other products. Endotoxins are lipopolysaccharide (LPS) components of the outer membrane of Gram-negative bacteria, which can trigger severe immune response in humans.
Sterility Testing:
Sterility testing is a critical quality control measure used to ensure the safety, efficacy, and quality of pharmaceuticals, medical devices, biologics, and other healthcare products.
By verifying the absence of viable microorganisms, sterility testing helps protect patients from the risk of infection or other adverse reactions associated with product contamination.
Environmental Monitoring (EM) Testing
Environmental Monitoring (EM) testing is a crucial component in assessing quality of controlled environments such as cleanroom, pharma or food manufacturing and production facilities. It may involve testing multiple aspects that may affect product integrity and sterility such as air, surfaces, personnel and utensils/equipment. This helps in ensuring organization compliance with regulatory standards such as GMP, ISO 1464 and FDA.
Yes. MyGenome ensures that our microbial test methods comply with regulatory and international standards of compliance. This includes Mycoplasma Detection (EP 2.6.7), Bacterial Endotoxin (USP <85>) and Sterility (USP <71>/EP (2.6.1)/JP (4.06)).
Mycoplasma & Bacterial Endotoxin Tests: within 2 working days following sample receive date.
Sterility Testing: within 16 working days following sample receive date.
Rapid Sterility Testing: within 24 hours
EM Testing: within 7 working days following sample receive date.
The BIOAGE test is a blood-based assessment that uses PhenoAge, a scientifically developed biological age model, to estimate how your body is aging internally. Instead of relying only on your actual age, it analyses key blood markers related to metabolism, inflammation, immune function, and organ health to provide a more complete picture of your overall health. Measuring biological age is worthwhile, as it has been shown to be a good predictor of maintaining health and longevity. Determining and monitoring your biological age can help you see changes over time and understand how diet, lifestyle changes, and anti-aging treatments affect your rate of aging.
Most adults (aged 18 and above) can take the test. It’s suitable for wellness monitoring and is not intended for medical diagnosis.
A BIOAGE test is best taken once a year, but individuals making significant lifestyle changes (such as cell therapy) may test every 3 – 6 months to track improvements.
PCI testing evaluates the potential risk of herb-drug interactions (HDI) or drug-drug interactions (DDI) using an in vitro CYP450 enzyme inhibition assay. This test is suitable for drugs, herbs, supplements, functional foods and etc
PCI testing is important to ensure the safe use of drugs, herbs, supplements, and functional foods when taken together with medication.
PCI is highly relevant for:
1. Nutraceutical and herbal product manufacturers
2. Pharmaceutical including compounding pharmacy
3. Researchers in drug discovery or herbal product development
PCI testing is conducted based on internationally accepted guidelines such as those from the U.S. Food and Drug Administration (FDA).
These guidelines are widely used in the pharmaceutical and research industry to assess drug interaction risks, making PCI a scientifically credible and globally aligned approach.
The data will be securely stored within our in-house systems, using strong security measures to protect privacy and ensure data integrity.
Please contact out marketing team, Globemedic, at 03-2181 5665, for further details on pricing and available packages at our lab.
Please call 019-266 6213 to speak to a Mandarin speaking staff
We are located at Suite No. 03-04, Ground Floor, Menara See Hoy Chan, No. 374, Jalan Tun Razak, Kuala Lumpur
You can reach us through:
Call / Whatsapp: 03-2161 6113
Call: 012-2665640
Email: info@mygenome.asia
Yes, carrier testing is a type of genetic testing that can identify whether you carry a mutation for certain genetic conditions, even if you do not have any symptoms of the condition yourself. This information can be useful for family planning and understanding your risk of passing on genetic conditions to your children.
Yes, genetic testing can be performed on children to determine their risk of inheriting a genetic condition from one or both parents. This information can be valuable for parents who may be carriers of a genetic mutation and want to understand their child’s risk and potential healthcare needs.
The interpretation of genetic testing results can be complex, so it’s important to discuss them with a healthcare provider or geneticist who can help you understand what they mean for your health and future medical care. They will provide guidance on any preventive measures or screening recommendations based on your results.
No, mRNA testing is not the same as DNA testing. DNA testing analyses an individual’s genetic material (DNA) to identify genetic variations, mutations, or predispositions to certain diseases. It provides information about an individual’s inherited genetic makeup. On the other hand, mRNA testing analyses messenger RNA (mRNA) molecules, which are used to produce proteins. mRNA testing is often used to measure gene expression levels, providing insights into which genes are active or inactive in a particular tissue or sample. While both types of testing are molecular techniques used in genetics and medical diagnostics, they serve different purposes.
The turnaround time would be 6 to 10 weeks.
Yes, mRNA testing can be used to monitor changes in gene expression patterns in response to cancer treatments, such as chemotherapy or targeted therapy. This information can help oncologists assess the effectiveness of treatment and make adjustments as needed to improve patient outcomes. While mRNA testing isn’t typically used as a direct method for monitoring treatment response in cancer patients, it can play a role in profiling the tumour microenvironment to predict response to immunotherapy at the time of diagnosis or during disease progression. Changes in gene expression profiles may occur over time. Monitoring these changes using mRNA testing isn’t a standard approach for assessing treatment response. Instead, treatment response is typically evaluated through various methods such as imaging scans, blood tests, and clinical assessments. mRNA testing’s primary role remains in predicting response to immunotherapy rather than directly monitoring treatment response.
Yes, we do provide COVID-19 PCR test.
Yes, but the prices for pre-booked and walk-in are different.
Go to, www.mygenome.asia and click on Our Services→ Medical Laboratory→ Molecular Tests→ COVID-19 RT-PCR to make your booking.
You should come at 8.30 am to 10.30 am (daily) for a swab test.
The COVID-19 PCR report will be release by 7 PM on the same day.
The COVID-19 PCR sample will be processed the following day and the report will be released before 7 PM.
Yes, we do provide microbial test for the purpose of product quality control.
Mycoplasma:
A mycoplasma test is used to detect the presence of mycoplasma (a group of bacteria that lack cell walls and can cause significant interference in research and bioproduction) contamination in biological samples such as cell cultures, tissue cultures and clinical specimens.
Bacterial Endotoxin Test:
Bacterial Endotoxins Test (BET), also known as the Limulus Amebocyte Lysate (LAL) test, is a widely used assay to detect and quantify endotoxins from Gram negative bacteria in pharmaceuticals, medical devices, and other products. Endotoxins are lipopolysaccharide (LPS) components of the outer membrane of Gram-negative bacteria, which can cause severe immune response in humans.
Sterility Testing:
Sterility testing is a critical quality control measure used to ensure the safety, efficacy, and quality of pharmaceuticals, medical devices, biologics, and other healthcare products.
By verifying the absence of viable microorganisms, sterility testing helps protect patients from the risk of infection or other adverse reactions associated with product contamination.
Yes. MyGenome ensure that our microbial test methods comply with regulatory and international standards of compliance. This includes Mycoplasma Detection (EP 2.6.7), Bacterial Endotoxin (USP <85>) and Sterility (USP <71>/EP (2.6.1)/JP (4.06)).
Mycoplasma & Bacterial Endotoxin Tests: within 2 days following sample receive date.
Sterility Testing: within 16 days following sample receive date.
Please contact out marketing team, Globemedic, at 03-2181 5665, for further details on pricing and available packages at our lab.
Please call 019-266 6213 to speak to a Mandarin speaking staff.
We are located at Suite No. 03-04, Ground Floor, Menara See Hoy Chan, No. 374, Jalan Tun Razak, Kuala Lumpur.
You can reach us through:
Call: 03-2161 6113
Email: info@mygenome.asia
Or through ALPS Global Holding Berhad
Call: 03-2163 1113
